tm logo
ZOLGENSMA
REGISTERED

on 08 Mar 2023

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2103192 filed on 18th Jan 2021

Registration Number

TMA1170266 registered on 08th Mar 2023

Registration expiry Date

18th Jan 2031

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

ZOLGENSMA

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

1 . 15 . 9

Luminous sources, rays, shafts of lightSources lumineuses, rayons, faisceaux de lumière

24 . 15 . 2

Two arrows, double-headed arrowsDeux flèches, flèches à deux têtes

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 5

VioletViolet

29 . 1 . 3

GreenVert

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Mark Details


Serial Number

2103192

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 10th Aug 2022
Agent Changed
Submitted for opposition 22
on 26th Jul 2022
Search Recorded
Submitted for opposition 20
on 26th Jul 2022
Examiner's First Report
Submitted for opposition 223
on 26th Jul 2022
Total Provisional Refusal
Submitted for opposition 256
on 28th Feb 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 29th Apr 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 28th Apr 2021
Created
Submitted for opposition 31
on 28th Apr 2021
Formalized
Submitted for opposition 228
on 18th Jan 2021
International Registration
Submitted for opposition 30
on 18th Jan 2021
Filed